| 3/21/2024 | 90189090 | Head, Face and Neck Oncology Surgical Instrument Set (Additional Set), Manufacturer: PRO MED Instrumente GmbH, 100% new goods, (Details of surgical instrument set according to the attached list HYS: 722094025460) | XXXXXXXXXX | 6 | SET | 22524.6 | Germany | NA |
| 3/21/2024 | 90189090 | Head, Face and Neck Oncology Surgical Instrument Set (Standard Set), Manufacturer: PRO MED Instrumente GmbH, 100% new goods, (Details of the surgical instrument set according to the attached list HYS: 722094025460) | XXXXXXXXXX | 2 | SET | 9683.06 | Germany | NA |
| 3/20/2024 | 30049099 | Dato-DXd medicine (DS-1062a) 100mg Dato-DXd lyophilized powder for mixing intravenous infusion solution, box of 1 vial. Lot 36195.1/1. Deadline May 31, 2026. Manufacturer Baxter Oncology GmbH. 100% New | XXXXXXXXXX | 23 | UNK | 2029.7684 | Germany | NA |
| 3/20/2024 | 30049099 | Dato-DXd medicine (DS-1062a) 100mg Dato-DXd lyophilized powder for mixing intravenous infusion solution, box of 1 vial. Lot 36195.1/1. Deadline May 31, 2026. Manufacturer Baxter Oncology GmbH. 100% New | XXXXXXXXXX | 23 | UNK | 2029.7684 | Germany | NA |
| 3/18/2024 | 30049089 | New medicine: Uromitexan (Mesna 400mg/4ml). Infusion liquid. Box of 15 tubes x 4ml. Lot: 3F749C. Production: June 2023. HD: May 2028. Registration number: VN-20658-17. Manufacturer: Baxter Oncology GmbH. | XXXXXXXXXX | 3388 | UNK | 81278.12 | Germany | NA |
| 3/18/2024 | 30049089 | New medicine: Holoxan (Ifosfamide 1 gram). Powder for injection. Box of 1 vial. Lot: 3J188A. Production: October 2023. HD: September 2027. Registration number: VN-9945-10. Manufacturer: Baxter Oncology GmbH. | XXXXXXXXXX | 8000 | UNK | 121760 | Germany | NA |
| 3/18/2024 | 30049089 | New medicine: Endoxan (Cyclophosphamide 500 mg). Powder for injection. Box of 01 vial. Lot: 3H190E. Production: August 2023. HD: July 2026. Registration number: VN-16582-13. Manufacturer: Baxter Oncology GmbH | XXXXXXXXXX | 12000 | UNK | 64200 | Germany | NA |
| 3/18/2024 | 30049089 | New medicine: Endoxan (Cyclophosphamide 200 mg). Powder for injection. Box of 01 vial. Lot: 3K640B. Production: November 2023. HD: October 2026. Registration number: VN-16581-13. Manufacturer: Baxter Oncology GmbH | XXXXXXXXXX | 24000 | UNK | 52800 | Germany | NA |
| 3/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (Datopotamab Deruxtecan 20mg/ml) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 60 | UNA | 5295.048 | Germany | NA |
| 3/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (Datopotamab Deruxtecan 20mg/ml) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 85 | UNA | 7501.318 | Germany | NA |